We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medtronic officials said Tuesday that a large donation to the Medtronic Foundation plus the ongoing acquisition of Covidien led to an 8 percent decline in earnings in the second-quarter of fiscal 2015 compared with the previous year. Read More
Cataract patients who also have astigmatism may soon have a new option for restoring vision, if the FDA heeds a recent advisory panel recommendation. Read More
Minneapolis, Minn.-based Vascular Solutions will not get a state subsidy for job creation in the wake of a federal fraud indictment issued against the company and its CEO. Read More
HHS officials highlighted progress in developing new Ebola diagnostics during a Wednesday House hearing, but acknowledged that more companies are looking for government support to move their products quickly to market. Read More
A study on the optimal length of dual antiplatelet therapy following implantation of a drug-eluting stent shows that 30 months is better than one year in preventing certain adverse outcomes. Read More
Australia and New Zealand have abandoned plans for a joint drug and device regulatory authority, although both countries say they will continue to cooperate on mutually beneficial regulations. Read More
The American Clinical Laboratory Association and American Medical Association are promising an all-out fight to stop the FDA from requiring premarket applications for high-risk laboratory-developed tests. Read More
Device and diagnostics makers would have to submit all clinical trial data to the federal government — including data for products never approved by the FDA — under a massive, proposed expansion of data collection. Read More